Clinical Trials Browser

Phase 3 × Drugs, Investigational × Gastrointestinal × Clear all

NCT05768503 2023-03-14

Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms